Screening

Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.

FDA clears St. Jude's intracardiac echo catheter

St. Jude Medical received 510(k) clearance from the FDA for the ViewFlex Xtra Intracardiac Echocardiography (ICE) catheter.

FDA places warnings on anti-nausea drug Zofran

Results of a clinical trial showed that the 32 mg dose of the anti-nausea drug ondansetron (Zofran) could negatively affect a patients heart. FDA and GlaxoSmithKline have placed warnings on the drug, saying that intravenous doses of the drug should not exceed 16 mg.

Health is better than wealth

Health is better than wealth, they say, but can you get there without money? Hospitals today face tough times as they attempt to balance top-notch patient care and dwindling resources. But while many say innovation will be the missing piece to the puzzle, will it be affordable?

FDA bulks up obesity drug market with Belviq approval

FDA has weighed in on the latest weight-loss drug lorcaserin hydrochloride (Belviq), approving the Arena Pharmaceutical drug for use in adults with a body mass index (BMI) of 30 or greater and those with a BMI more than 27 and hypertension, type 2 diabetes or dyslipidemia.

CCHIT questions governance, security of NwHIN

The Certification Commission for Health IT (CCHIT) focused its comments this week on the request for information (RFI) on governance and security of the Nationwide Health Information Network (NwHIN), published in the Federal Register by the Office of the National Coordinator for Health IT (ONC) on May 15.

FDA panel gives nod to Dune's breast cancer surgical device

The FDA Advisory Panel voted (10 to one) in favor of Dune Medical Device's MarginProbe System for use in breast cancer surgery, as an adjunct to current standard methods of intraoperative surgical margin assessment.

The best laid plans

When we conceived of the Health Imaging Best of Fridays, the plan was to recap the top news of the week and offer a bit of insightful analysis. This morning, however, news seems to be coming out in firehose fashion.

Men need osteoporosis screening, too, says Endocrine Society

The Endocrine Society has issued a new set of clinical guidelines urging some men to get bone density scans to check for osteoporosis. The updated clinical practice guideline was published in the June issue of the Journal of Clinical Endocrinology and Metabolism.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.